| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0306-4522(98)00524-7 |
| P698 | PubMed publication ID | 10218792 |
| P50 | author | Miles Herkenham | Q47816901 |
| P2093 | author name string | Hohmann AG | |
| P2860 | cites work | The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain | Q28236298 |
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons | Q28245016 | ||
| D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. | Q34554719 | ||
| Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A | Q34594580 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system | Q34745063 | ||
| Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves | Q35874165 | ||
| Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells | Q37599138 | ||
| Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry | Q38331458 | ||
| Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. | Q38340750 | ||
| Neuropeptides in morphologically and functionally identified primary afferent neurons in dorsal root ganglia: substance P, CGRP and somatostatin. | Q40940886 | ||
| Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. | Q41292913 | ||
| Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of delta 9-tetrahydrocannabinol in mice | Q41664976 | ||
| Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons | Q42450378 | ||
| Plasticity in the synthesis and storage of substance P and calcitonin gene-related peptide in primary afferent neurons during peripheral inflammation | Q42474375 | ||
| Localization of cannabinoid receptor mRNA in rat brain | Q42510202 | ||
| Alterations in myelinated fibres in the sciatic nerve of rats after constriction: possible relationships between the presence of abnormal small myelinated fibres and pain-related behaviour | Q43479571 | ||
| Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons | Q43741458 | ||
| Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. | Q44020270 | ||
| Double in situ hybridization study on coexistence of mu-, delta- and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia | Q44333074 | ||
| Expression of mu- and kappa-, but not delta-, opioid receptor mRNAs is enhanced in the spinal dorsal horn of the arthritic rats | Q44342268 | ||
| Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment | Q44350109 | ||
| Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study | Q45078410 | ||
| Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. | Q46210588 | ||
| Distribution of neurons expressing calcitonin gene-related peptide mRNAs in the brain stem, spinal cord and dorsal root ganglia of rat and guinea-pig | Q46314115 | ||
| The spectrum of fiber loss in a model of neuropathic pain in the rat: an electron microscopic study | Q46333849 | ||
| Antihyperalgesic effects of spinal cannabinoids | Q47625816 | ||
| Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors | Q47626156 | ||
| Glutamate-like immunoreactive structures in primary sensory neurons in the rat detected by a specific antiserum against glutamate | Q48258041 | ||
| Somatostatin mRNA: regional variation in hybridization densities in individual neurons | Q48285041 | ||
| Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide | Q48375356 | ||
| Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices | Q48726145 | ||
| Semi-quantitative analysis of somatostatin mRNA distribution in the rat central nervous system using in situ hybridization | Q48789368 | ||
| Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects | Q48890570 | ||
| Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures | Q48963650 | ||
| Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous system. | Q52070173 | ||
| Neuroma formation and numbers of axons in a rat model of experimental peripheral neuropathy. | Q52481047 | ||
| Distribution of somatostatin mRNA containing neurons in the primary pain relaying nuclei of the rat | Q57855851 | ||
| Fluoride-resistant acid phosphatase-containing neurones in dorsal root ganglia are separate from those containing substance P or somatostatin | Q58493713 | ||
| Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2 | Q60149864 | ||
| Distribution of somatostatin mRNA in the rat nervous system as visualized by a novel non-radioactive in situ hybridization histochemistry procedure | Q60684695 | ||
| Co-expression of alpha-CGRP and beta-CGRP mRNAs in the rat dorsal root ganglion cells | Q68711048 | ||
| Cell type and conduction velocity of rat primary sensory neurons with calcitonin gene-related peptide-like immunoreactivity | Q68813314 | ||
| Cell type and conduction velocity of rat primary sensory neurons with substance P-like immunoreactivity | Q69062076 | ||
| Abnormal discharge originates at the site of nerve injury in experimental constriction neuropathy (CCI) in the rat | Q71474700 | ||
| Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain | Q71658368 | ||
| The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat | Q71856943 | ||
| A method for simultaneous detection of multiple mRNAs using digoxigenin and radioisotopic cRNA probes | Q72620461 | ||
| Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist | Q73337499 | ||
| Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat | Q74184497 | ||
| Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study | Q74184554 | ||
| Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2 | Q77740584 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 923-931 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. | |
| P478 | volume | 90 |
| Q38370304 | A Review of Spasticity Treatments: Pharmacological and Interventional Approaches. |
| Q37067266 | A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain |
| Q44345700 | A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation |
| Q44205907 | A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. |
| Q35843085 | A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons |
| Q34094132 | A role for the endogenous cannabinoid system in the peripheral control of pain initiation |
| Q37740479 | A systematic review of pharmacologic treatments of pain after spinal cord injury |
| Q34049519 | Acid-sensing ion channels (ASICs): therapeutic targets for neurological diseases and their regulation |
| Q43511723 | Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception |
| Q24683100 | Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS |
| Q45022904 | Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation |
| Q42625887 | Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis |
| Q44658192 | Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation |
| Q42490287 | Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats |
| Q40818985 | Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. |
| Q26824588 | Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases |
| Q31839936 | Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. |
| Q38185073 | Anandamide in primary sensory neurons: too much of a good thing? |
| Q43901271 | Anandamide inhibits excitatory transmission to rat substantia gelatinosa neurones in a manner different from that of capsaicin |
| Q35678770 | Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. |
| Q60690621 | Anandamide – the other side of the coin |
| Q33953174 | Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. |
| Q41038624 | Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists. |
| Q91959308 | Biological bases for a possible effect of cannabidiol in Parkinson's disease |
| Q57058269 | Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase synergize with the opioid analgesic morphine to suppress chemotherapy-induced neuropathic nociception without enhancing effects of morphine on gastrointestinal transit |
| Q28344830 | CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord |
| Q34098185 | CB2: a cannabinoid receptor with an identity crisis |
| Q42129148 | Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity. |
| Q39598750 | Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones. |
| Q39549838 | Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. |
| Q33803774 | Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization |
| Q44551678 | Cannabinoid CB1 receptor inhibition of mechanically evoked responses of spinal neurones in control rats, but not in rats with hindpaw inflammation |
| Q35763485 | Cannabinoid CB2 receptors contribute to upregulation of β-endorphin in inflamed skin tissues by electroacupuncture. |
| Q43596412 | Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed. |
| Q36978586 | Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation |
| Q34214210 | Cannabinoid modulation of peripheral autonomic and sensory neurotransmission |
| Q34921927 | Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. |
| Q77740584 | Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2 |
| Q28143655 | Cannabinoid receptors and pain |
| Q51982869 | Cannabinoid receptors undergo axonal flow in sensory nerves. |
| Q43543029 | Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit |
| Q39415164 | Cannabinoids and pain relief |
| Q34019573 | Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside |
| Q44209120 | Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats |
| Q34429295 | Cannabinoids inhibit acid-sensing ion channel currents in rat dorsal root ganglion neurons |
| Q36447081 | Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors |
| Q36892931 | Cannabis and endocannabinoid modulators: Therapeutic promises and challenges |
| Q34786849 | Cardiovascular effects of cannabinoids |
| Q47804552 | Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly |
| Q90682483 | Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia |
| Q36990269 | Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons |
| Q34631608 | Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors |
| Q37077524 | Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice |
| Q38707482 | Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? |
| Q44102435 | Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus. |
| Q36752224 | Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density |
| Q41941144 | Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs. spinally-innervated skin |
| Q44344553 | Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. |
| Q37284886 | Differential effects of the cannabinoid receptor agonist, WIN 55,212-2, on lamina I and lamina V spinal trigeminal nucleus caudalis neurons |
| Q44710513 | Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves |
| Q38593117 | Distribution of the Endocannabinoid System in the Central Nervous System |
| Q38211191 | Dronabinol and chronic pain: importance of mechanistic considerations |
| Q37495207 | Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. |
| Q48186911 | Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors |
| Q34274062 | Endocannabinoid involvement in endometriosis. |
| Q38154691 | Endocannabinoid system and pain: an introduction |
| Q48639515 | Endocannabinoid-dependent plasticity at spinal nociceptor synapses |
| Q37363621 | Endocannabinoid-mediated control of synaptic transmission |
| Q34351200 | Endocannabinoids and exercise |
| Q34099017 | Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders |
| Q43540715 | Evidence for an endocannabinoid system in the central nervous system of the leech Hirudo medicinalis |
| Q37650292 | Examining the roles of cannabinoids in pain and other therapeutic indications: a review |
| Q43782827 | Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats |
| Q30385233 | G protein-coupled receptor heterocomplexes in neuropsychiatric disorders. |
| Q89554788 | Histone methyltransferase G9a diminishes expression of cannabinoid CB1 receptors in primary sensory neurons in neuropathic pain |
| Q60731287 | Increased Cannabinoid Receptor 1-Immunoreactive Nerve Fibers in Overactive and Painful Bladder Disorders and Their Correlation With Symptoms |
| Q83973717 | Inhibition of 5-HT(3) receptors-activated currents by cannabinoids in rat trigeminal ganglion neurons |
| Q35035855 | Inhibition of pain responses by activation of CB(2) cannabinoid receptors |
| Q42034148 | Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms |
| Q44692991 | Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation |
| Q35752224 | Involvement of cannabinoid receptors in gut motility and visceral perception |
| Q38185076 | Involvement of the endocannabinoid system in osteoarthritis pain |
| Q64212082 | Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry |
| Q28755529 | Localization of CB1 cannabinoid receptor mRNA in the brain of the chick (Gallus domesticus) |
| Q46074720 | Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury. |
| Q34440671 | Mechanisms of exercise-induced hypoalgesia |
| Q28238995 | Mode of action of cannabinoids on nociceptive nerve endings |
| Q34247711 | Modulation of pain transmission by G-protein-coupled receptors |
| Q39650639 | Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites |
| Q37216017 | Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. |
| Q35047032 | Multiple actions of anandamide on neonatal rat cultured sensory neurones |
| Q74571194 | Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord |
| Q34046213 | New perspectives on enigmatic vanilloid receptors. |
| Q47837489 | New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agents |
| Q38287127 | Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain |
| Q33608432 | Peripheral gating of pain signals by endogenous lipid mediators |
| Q90451168 | Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats |
| Q41906880 | Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist |
| Q98896096 | PnAn13, an antinociceptive synthetic peptide inspired in the Phoneutria nigriventer toxin PnTx4(6-1) (δ-Ctenitoxin-Pn1a) |
| Q34430635 | Possible mechanisms of cannabinoid-induced antinociception in the spinal cord |
| Q55002764 | Potential of Endocannabinoids to Control Bladder Pain. |
| Q44351566 | Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord |
| Q43948450 | Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. |
| Q42726526 | Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network. |
| Q39135834 | Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. |
| Q33527067 | Recent data on cannabinoids and their pharmacological implications in neuropathic pain |
| Q24794310 | Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury |
| Q36726650 | Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes |
| Q44650597 | Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin |
| Q34206319 | Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation |
| Q43814527 | Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo |
| Q53692390 | Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis. |
| Q37337607 | Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain? |
| Q36618089 | Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability |
| Q35600288 | Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. |
| Q60916595 | Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55 |
| Q37274198 | Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk. |
| Q33897801 | Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system |
| Q35035850 | Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives |
| Q37529127 | Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure |
| Q33992517 | Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2). |
| Q28271125 | TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat |
| Q37371095 | Targeting CB2 receptors and the endocannabinoid system for the treatment of pain |
| Q89861376 | Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain |
| Q37382150 | Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation |
| Q37960078 | Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies. |
| Q38600704 | The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. |
| Q38822341 | The Role of the Endocannabinoid System in the Brain-Gut Axis |
| Q30733453 | The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model |
| Q35029262 | The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat. |
| Q24676808 | The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin |
| Q37182268 | The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms |
| Q35226232 | The cannabinoid system: a role in both the homeostatic and hedonic control of eating? |
| Q84616297 | The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice |
| Q44031615 | The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. |
| Q39697570 | The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats |
| Q34612917 | The endocannabinoid system and pain |
| Q33934278 | The endocannabinoid system as a target for therapeutic drugs. |
| Q28354238 | The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways |
| Q24522320 | The neurobiology and evolution of cannabinoid signalling |
| Q33720138 | The neurobiology of cannabinoid analgesia |
| Q35854891 | The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. |
| Q37120771 | The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain |
| Q35921090 | The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications |
| Q28362063 | The role of sensory nerve endings in nerve growth factor-induced airway hyperresponsiveness to histamine in guinea-pigs |
| Q36187065 | Therapeutic potential of cannabinoid receptor agonists as analgesic agents |
| Q45269970 | Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. |
| Q35915645 | Update on the role of cannabinoid receptors after ischemic stroke |
| Q74501955 | [The pharmacology of cannabinoid derivatives: are there applications to treatment of pain?] |
Search more.